PHARMACEUTICAL COMPOSITION FOR TUMOR HAVING ISOCITRATE DEHYDROGENASE MUTATION, ANTITUMOR AGENT AND USE THEREOF.

摘要

The purpose of the present invention is to provide a pharmaceutical composition which exhibits an effect against tumors having an isocitrate dehydrogenase mutation, and an antitumor agent. A pharmaceutical composition for treating a tumor having an isocitrate dehydrogenase mutation is provided that contains 1-(2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranosyl)cytosine or a salt or a prodrug thereof.